Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-sarepta-ed-kaye.jpg" NAME"Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million" ALT"Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for…

Continue ReadingSarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million

Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback" ALT"Rumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated…

Continue ReadingRumored Acquisition Target Bristol-Myers Squibb Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback

This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-celgene.jpg" NAME"This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene" ALT"This Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene"February 20, 2017By…

Continue ReadingThis Drug Could Rattle Biogen and Be the Next Billion-Dollar Blockbuster for Celgene

Meet the Professor Who Was the First to Question Theranos' Research

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stanford-john-ioannidis.jpg" NAME"Meet the Professor Who Was the First to Question Theranos' Research" ALT"Meet the Professor Who Was the First to Question Theranos' Research"February 20, 2017By Alex Keown, BioSpace.com... Source:…

Continue ReadingMeet the Professor Who Was the First to Question Theranos' Research